Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Social Media in the Pharmaceutical Industry

22 Jan 2014 - 23 Jan 2014 - London, UK



Bookmark and Share


SMi is pleased to present the 6th instalment in the sell out Social Media Pharmaceutical conference series which returns to London on 22nd and 23rd January 2014.

With health at the top of any patient’s agenda the opportunity for health professionals to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.

Join our panel of leading industry speakers, from Big Pharma companies to cutting edge developers at the heart of social media technology today. You simply cannot afford to miss out.

Reasons to Attend:

Learn about the cutting edge developments in social media including personalised marketing techniques, mobile platforms, remote monitoring and open stakeholder engagement.

Share ideas with leading technology providers; discuss the industry requirements and learn what technological solutions are available.

Hear how major pharmaceutical companies are actually applying the latest developments in social media in a practical way.

Analyse how social media will allow your organisation to better communicate and interact with your stakeholders.

Expert Speaker Line-up includes:

Doris Cesares, Director of Communication, AESEG

Sherri Matis-Mitchell, R and D, Astra Zeneca 

Neeraj Goel Mittal, Business Intelligence Manager, AbbVie 

Dr. Alfred R. Steinhardt, Founder, Alfred Steinhardt Consulting

Piotr Wrzosinski, Digital Marketing, Roche 

Ben Furber, Asthma UK

Claire Perrin, European Brand Leader, Eli Lilly

Alexandra Fulford, Consultant, Pharmaguapa 

Gizem Bicakci, eMarketing, Boehringer-Ingelheim 

Matt Evans, Chief Medical Officer, Health Unlocked 

Todd Kolm, Vice-President, Head of Global Digital Strategy, Sanofi

James Finney, Project Manager, Global Comm. Services, Novozymes Biopharma

Shona Davies, Communication and Programme Leader, Merck

For further details and to register, visit http://www.smi-online.co.uk/goto/2014social-media-pharma26.asp 

Alternatively contact John Collins on +44 (0)20 7827 6000 or email jcollins@smi-online.co.uk 

Join the conversation on Twitter @smigrouppharm | #pharmasocialmedia



Further information
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Study Identifies How Brain Connects Memories Across Time
UCLA Neuroscientists have boost ability of aging brain to recapture links between related memories.
3-D Atomic Structure of Cholesterol Transporter
Researchers at UTSW have determined the 3-D atomic structure of a human sterol transporter that helps maintain cholesterol balance.
First Large-Scale Proteogenomic Study of Breast Cancer
The study offers understanding of potential therapeutic targets.
Can We Break the Link Between Obesity and Diabetes?
Columbia University researchers identify a key molecule involved in the development of type 2 diabetes.
Fungi – A Promising Source Of Chemical Diversity
Moulds and plants share similar ways in alkaloid biosynthesis .
How Prions Kill Neurons: New Culture System Shows Early Toxicity to Dendritic Spines
Boston University researchers have developed a cell culture system to study prions.
Great Migration and African-American genomic diversity
Study examines genetic data to analyze regional differences in ancestry.
Faster, More Efficient CRISPR Editing
UC Berkeley scientists have developed a quicker and more efficient method to alter the genes of mice with CRISPR-Cas9, simplifying a procedure growing in popularity because of the ease of using the new gene-editing tool.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!